Allegion heads into its July 23 earnings print with short interest still expanding — now at its highest monthly pace in months — while options traders remain notably unbothered by the approaching catalyst.
The short-side rebuild has continued since the last note. Short interest has risen 38% over the past month to 5.3% of the free float, up from 4.9% reported eight days ago. The weekly pace has also accelerated, with shorts adding roughly 8.5% in the past week alone. The ORTEX short score has held near 43 — elevated but not extreme — consistent with steady pressure rather than a sudden bearish surge. Despite the growth in short positions, the lending market tells a different story: borrow availability has actually loosened over the past week, climbing to 1,113% from around 813% — meaning there are more than eleven shares available to borrow for every one already shorted. The cost to borrow has ticked up 30% on the week to 0.60%, but at that level it remains firmly in "cheap and easy" territory. Shorts are piling in, but there is no scarcity of supply to create a squeeze.
Options positioning reinforces the calm. The put/call ratio has slipped to 0.25, modestly below its 20-day average of 0.31 and well inside the year's defensive extremes. That reading points to call-side tilt rather than protection-buying — an unusual posture given the trajectory of the short book. The stock itself has drifted sideways: up less than 0.5% on the week and just 1.8% over the past month, closing at $137.24.
The analyst consensus frames the debate clearly. The Street's hold consensus has been accompanied by a string of target cuts stretching from early April through June, with Morgan Stanley lowering to $142 in early June and JPMorgan downgrading to Neutral in mid-May. The mean target of $165 implies roughly 20% upside from current levels, but that gap has widened largely because the stock has underperformed rather than because estimates have improved. EPS momentum ranks in the bottom third of the universe on both 30-day and 90-day measures, while the forward earnings growth factor sits in the 85th percentile — a split that suggests analysts see a longer-dated recovery story rather than near-term beat potential. The last print, in late April, delivered a 7.4% single-day decline followed by a further 11% drop over five days — a pattern that sets a clear reference point for what a disappointing result can cost.
Thursday's print is therefore less about whether Allegion can grow and more about whether management can demonstrate that the margin pressures and softer residential demand that weighed on Q1 are stabilising — a question the rebuilding short base suggests the market is not yet prepared to answer in the bulls' favour.
See the live data behind this article on ORTEX.
Open ALLE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
